68 related articles for article (PubMed ID: 9544674)
21. Technical considerations for acquiring and processing indium-111 capromab pendetide images.
Williams BS; Hinkle GH; Lamatrice RA; Fry JP; Loesch JA; Olsen JO
J Nucl Med Technol; 1997 Sep; 25(3):205-16. PubMed ID: 9291068
[TBL] [Abstract][Full Text] [Related]
22. Role of radioimmunolocalization in the staging of gastric carcinoma.
Mussa A; Sandrucci S; Mobiglia A; Baccega M; Mussa B; De Filippi PG
Semin Surg Oncol; 1998 Dec; 15(4):209-11. PubMed ID: 9829372
[TBL] [Abstract][Full Text] [Related]
23. The role of (111)In Capromab Pendetide (Prosta-ScintR) immunoscintigraphy in the management of prostate cancer.
Freeman LM; Krynyckyi BR; Li Y; Korupulu G; Saleemi K; Haseman MK; Kahn D;
Q J Nucl Med; 2002 Jun; 46(2):131-7. PubMed ID: 12114876
[TBL] [Abstract][Full Text] [Related]
24. Editorial comment. Capromab pendetide scanning has a potential role in optimizing patient selection for salvage cryosurgical ablation of the prostate.
Shore ND
Urology; 2010 Nov; 76(5):1167-8; author reply 1168. PubMed ID: 21056261
[No Abstract] [Full Text] [Related]
25. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
[TBL] [Abstract][Full Text] [Related]
26. ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology.
Wong TZ; Turkington TG; Polascik TJ; Coleman RE
AJR Am J Roentgenol; 2005 Feb; 184(2):676-80. PubMed ID: 15671397
[No Abstract] [Full Text] [Related]
27. Detection of a non-Hodgkin's lymphoma by capromab pendetide scintigraphy (ProstaScint) in a patient with prostate carcinoma.
Zanzi I; Stark R
Urology; 2002 Sep; 60(3):514. PubMed ID: 12350503
[TBL] [Abstract][Full Text] [Related]
28. Computed tomographic detection of pelvic and inguinal lymph-node metastases from primary and recurrent pelvic malignant disease.
Walsh JW; Amendola MA; Konerding KF; Tisnado J; Hazra TA
Radiology; 1980 Oct; 137(1 Pt 1):157-66. PubMed ID: 7422839
[TBL] [Abstract][Full Text] [Related]
29. Indium-111 capromab pendetide (ProstaScint) uptake in a meningioma.
Zucker RJ; Bradley YC
Clin Nucl Med; 2001 Jun; 26(6):568-9. PubMed ID: 11353317
[No Abstract] [Full Text] [Related]
30. Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody.
Engelstad BL; Spitler LE; Del Rio MJ; Ramos EC; Rosendorf LL; Reinhold CE; Khentigan A; Huberty JP; Corpuz SW; Lee HM
Radiology; 1986 Nov; 161(2):419-22. PubMed ID: 3763912
[TBL] [Abstract][Full Text] [Related]
31. Intense uptake of In-111 satumomab pendetide in an inflammatory mass.
Silberstein EB; Saeks E
Clin Nucl Med; 1996 Jan; 21(1):53-5. PubMed ID: 8741891
[TBL] [Abstract][Full Text] [Related]
32. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49.
Cote RJ; Houchens DP; Hitchcock CL; Saad AD; Nines RG; Greenson JK; Schneebaum S; Arnold MW; Martin EW
Cancer; 1996 Feb; 77(4):613-20. PubMed ID: 8616751
[TBL] [Abstract][Full Text] [Related]
33. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.
Dhar NB; Studer UE
Nat Clin Pract Urol; 2007 Oct; 4(10):520-1. PubMed ID: 17726432
[No Abstract] [Full Text] [Related]
34. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
Harisinghani MG; Barentsz J; Hahn PF; Deserno WM; Tabatabaei S; van de Kaa CH; de la Rosette J; Weissleder R
N Engl J Med; 2003 Jun; 348(25):2491-9. PubMed ID: 12815134
[TBL] [Abstract][Full Text] [Related]
35. Immunoscintigraphy of primary colorectal cancers with indium-111 monoclonal antibody B72.3.
Joypaul BV; Kennedy N; Hanson J; Holley M; Browning M; Newman EL; Cuschieri A
J R Coll Surg Edinb; 1994 Feb; 39(1):39-43. PubMed ID: 7515429
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody imaging in colon cancer: a transition from basic science to clinical application.
Kim SL; Goldschmid S
Am J Gastroenterol; 1994 Oct; 89(10):1910-2. PubMed ID: 7942701
[No Abstract] [Full Text] [Related]
37. 111Indium-capromab pendetide unexpectedly localizes to renal cell carcinoma.
Michaels EK; Blend M; Quintana JC
J Urol; 1999 Feb; 161(2):597-8. PubMed ID: 9915456
[No Abstract] [Full Text] [Related]
38. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
Barbet J; Peltier P; Bardet S; Vuillez JP; Bachelot I; Denet S; Olivier P; Leccia F; Corcuff B; Huglo D; Proye C; Rouvier E; Meyer P; Chatal JF
J Nucl Med; 1998 Jul; 39(7):1172-8. PubMed ID: 9669389
[TBL] [Abstract][Full Text] [Related]
39. Use of MRI to detect lymph-node metastases in prostate cancer.
Yaes RJ
N Engl J Med; 2003 Sep; 349(12):1185-6; author reply 1185-6. PubMed ID: 13679535
[No Abstract] [Full Text] [Related]
40. The prognostic significance of indium-111-capromab penetide.
Sodee DB; Faulhaber PF; Nelson AD; Bakale G
J Clin Oncol; 2004 Jan; 22(2):379-80; author reply 380-1. PubMed ID: 14722051
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
